Multiparameter Evaluation of the Platelet-Inhibitory Effects of Tyrosine Kinase Inhibitors Used for Cancer Treatment

B.M.E. Tullemans, A. Veninga, D.I. Fernandez, M.J.B. Aarts, J.A. Eble, P.E.J. van der Meijden, J.W.M. Heemskerk, M.J.E. Kuijpers*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number11199
Number of pages18
JournalInternational Journal of Molecular Sciences
Volume22
Issue number20
DOIs
Publication statusPublished - 1 Oct 2021

Keywords

  • platelet activation
  • aggregation
  • bleeding
  • thrombus formation
  • tyrosine kinase inhibitors
  • antiplatelet treatment
  • IN-VIVO DEPLETION
  • GLYCOPROTEIN-VI
  • THROMBUS FORMATION
  • RECEPTOR CLEC-2
  • ACTIVATION
  • GPVI
  • EXPRESSION
  • DEFICIENT
  • INTEGRIN
  • BLOOD

Cite this